Navigation Links
FDA to Broaden Disclosure on Advisers' Conflicts of Interest
Date:4/21/2010

Agency has faced criticism in the past over the issue

WEDNESDAY, April 21 (HealthDay News) -- The U.S. Food and Drug Administration on Wednesday proposed new guidelines to help give the public more information on the experts the agency places on its all-important advisory committees, which help approve drugs and devices.

The FDA has in the past been criticized for allowing individuals with conflict of interests to serve on these panels. In some cases, prospective committee members with financial or other ties to a product under discussion can still receive special conflict-of-interest waivers that allow their participation on an advisory panel.

But on Wednesday the agency proposed new guidelines that, in its words, would "expand transparency and [public] disclosure" whenever one of these waivers are handed out.

FDA advisory committees provide the agency with advice on a wide range of topics, including drugs, medical devices and tobacco. They also provide key advice on regulatory decisions, such as product approvals and general policy matters. While the FDA is not bound to follow its committees' recommendations, it usually does.

"The primary goal of the advisory committee process is to bring high-quality input to FDA to inform our decision making," Jill Hartzler Warner, the FDA's acting associate commissioner for special medical programs, explained during a press conference Wednesday.

The new guidelines would expand the information disclosed to the public whenever the FDA grants a conflict-of-interest waiver, Warner said.

The FDA has 49 advisory committees with room for more than 600 members. Currently, there are over 200 vacancies on these committees, according to the agency.

Under the proposed guidelines, the FDA would disclose conflict-of-interest waivers before committee meetings, naming the company or institution and any financial interest advisers might have as well as the specific conflict of interest.

"In my view, it is clearly better for the agency in fulfilling its public health mission when advisers have no conflicts of interest," FDA Commissioner Dr. Margaret A. Hamburg wrote in a letter to senior agency officials. "FDA staff should search far and wide for experts who have the requisite knowledge without conflicts of interest. At the same time, however, I recognize the fact that many of the top authorities in specific areas may have conflicts of interest."

In the letter, Hamburg outlined three steps to consider before a conflict-of-interest waiver is given. These include:

  • Defining the nature of the conflict of interest before recommending giving a waiver. "Not all conflicts are created equal. For example, an academic researcher whose institution receives grants from an affected company but who does not personally participate in the studies has a more tangential relationship to the conflict than the researcher who conducts studies for the company directly," she wrote.
  • Weighing the kind of advice the committee is being asked for. "A waiver may be more appropriate for a meeting about a policy issue affecting a class of entities or products than for a meeting focusing on approval of a specific product," Hamburg explained.
  • Determining why expert advisers without conflicts could not be found and why the individual under scrutiny is needed.

"Conflict-of-interest waivers for scientific advisers have been controversial, however," Hamburg wrote. "If FDA is perceived to rely heavily on conflicted experts, then confidence in the agency's decision-making can be undermined."

More information

For more on the proposed guidelines, visit the U.S. Food and Drug Administration.



SOURCES: April 21, 2010, teleconference with Jill Hartzler Warner, J.D., acting associate commissioner for special medical programs, U.S. Food and Drug Administration; April 21, 2010, letter, Margaret A. Hamburg, M.D., commissioner, U.S. Food and Drug Administration


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Healthy Aging Global Leader Broadens Patient Exercise/Nutrition Success With Online Living Site
2. SOKO Fitness & Spa Group Broadens Geographic Expansion Strategy
3. Pivot Networks and Brookside Technology Partners, Inc. Team to Broaden Managed IT Services Offering for Texas SMBs
4. BD Applauds PEPFARs Broadened Emphasis on Strengthening Health Systems
5. Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research
6. Vend Marketing Institute Calls on Congress to Modify Calorie Disclosure Requirement: Supports Existing Disclosure Which Is More Complete and Effective
7. FDA Advisers Urge Stricter Regulation of Tanning Beds
8. Primary care physicians nationwide face clinical ethical conflicts with religious hospitals
9. Couples who say we do better at resolving conflicts
10. NursePractitionerBusinessOwner.com Announces No-Charge Teleseminar for Nurse Practitioners Interested in Starting Their Own Practice
11. Study shows strong interest in palliative care programs, services and integration vary across nation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar , sponsored ... a tool to characterize particle size distributions in the field of geoscience and ... novel scientific findings. It describes methods of optimized and standardized sample collection, preparation ...
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from ... scientific studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society ... B. Liegner, M.D. has compiled into a single volume a compelling argument that the ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health Centre ... Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of ... showcases the Centre's commitment to innovation in drug rehab and alcohol treatment strategies ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... and environs, is proud to announce an upgrade to the company's Yelp listing. ... Yelp page on topics as diverse as Platelet Rich Plasma (PRP) therapy, hair ...
(Date:2/26/2017)... , ... February 25, 2017 , ... The February 13, ... heightened awareness and concern over nerve agents and the deadly use of chemical weapons. ... nervous system and how even small doses can be lethal. , Jay Jagannathan, M.D., ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ) ... th Annual Healthcare Conference on Monday, March 6, ... MA. A live webcast of Infinity,s presentation ... website at www.infi.com , and will be available ... Infinity,Infinity is an innovative biopharmaceutical company dedicated to advancing ...
(Date:2/27/2017)... Inc. (NASDAQ: IPXL ) today announced that it plans to ... Raymond James and Associates, 38 th Annual Institutional Investors Conference ... FL. Cowen and Company 37 th ... in Boston, MA. Barclays Global ... Miami, FL. Individuals may listen to ...
(Date:2/27/2017)... -- A recent research report published by Grand View ... expected to reach a value of $55.8 billion by 2025. Earlier ... states have legalized marijuana for medical uses. In 2016, states such ... North Dakota , Ohio ... drug in medical applications such as chemotherapies and pain management. The ...
Breaking Medicine Technology: